Chromadex Corp
NASDAQ:CDXC
Chromadex Corp
NASDAQ:CDXC
Price:
3.69 USD
-2.64%
Market Closed
Updated:
Apr 20, 2024
Chromadex Corp
Revenue
Last
Value
3-Years CAGR
5-Years CAGR
|
Chromadex Corp
Revenue Peer Comparison
Comparables:
TMO
DHR
WST
A
IQV
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Chromadex Corp
NASDAQ:CDXC
|
Revenue
$83.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
22%
|
CAGR 10-Years
23%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$23.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Revenue
$2.9B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
Chromadex Corp
Revenue Breakdown
Breakdown by Geography
Chromadex Corp
Chromadex Corp
Not Available
Breakdown by Segments
Chromadex Corp
Chromadex Corp
|
Total Revenue:
83.6m
USD
|
|
Consumer Products Segment:
69.5m
USD
|
|
Ingredients Segment:
11.1m
USD
|
|
Analytical Reference Standards And Services S...:
2.9m
USD
|
See Also
What is Chromadex Corp's Revenue?
Revenue
83.6m
USD
83.6m
USD
Based on the financial report for Dec 31, 2023, Chromadex Corp's Revenue amounts to 83.6m USD.
What is Chromadex Corp's Revenue growth rate?
Revenue CAGR 10Y
23%
23%
Over the last year, the Revenue growth was 16%. The average annual Revenue growth rates for Chromadex Corp have been 12% over the past three years , 22% over the past five years , and 23% over the past ten years .
You don't have any saved screeners yet
